Reevaluating Sex Reassignment

Graphic: Cathleen Heard Results of two studies from the Johns Hopkins Children's Center challenge accepted medical practice of "sex reassignment"--surgically converting XY males with absent or minuscule penises into anatomical females, then raising them as girls. The investigations, which are the first to go beyond individual case reports, reveal outcomes that are remarkably consistent with rare instances of infants who lost their penises in accidents and who were reassigned as females. Both cli

Written byRicki Lewis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Graphic: Cathleen Heard
Results of two studies from the Johns Hopkins Children's Center challenge accepted medical practice of "sex reassignment"--surgically converting XY males with absent or minuscule penises into anatomical females, then raising them as girls. The investigations, which are the first to go beyond individual case reports, reveal outcomes that are remarkably consistent with rare instances of infants who lost their penises in accidents and who were reassigned as females. Both clinical trials and case reports powerfully argue for nature over nurture in establishing gender identity.

William Reiner, a child and adolescent psychiatrist and urologist at the Johns Hopkins Children's Center, reported the studies at the Lawson Wilkins Pediatric Endocrine Society meeting in Boston on May 12, 2000. "These children demonstrate that normal male gender identity can develop not only in the absence of the penis, but even after the removal of the testicles and unequivocal rearing as female. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies